SCHEMBL17876318

SCHEMBL17876318

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccc2c(c1)-c1cc(-c3cc(-c4ccncc4)cc(-c4ccncc4)c3)ccc1CN(c1ccccc1)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.36
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
CYP19A1 P11511 1/20 0.33
ROCK2 O75116 1/20 0.32
ROCK1 Q13464 1/20 0.32
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31
TRPA1 O75762 1/20 0.31
HRH1 P35367 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
GPR142 Q7Z601 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.30
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
DRD3 P35462 1/20 0.30
PTGER4 P35408 1/20 0.30
MAPKAPK2 P49137 1/20 0.30
MAP4K1 Q92918 1/20 0.30
TNKS2 Q9H2K2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17877877 0.94 PRKDC (0.33) ROCK2HRH3DRD2DRD4DRD3
SCHEMBL17877880 0.91 CYP11B2 (0.41) FLT3CYP11B1CYP11B2CYP19A1PIM1
SCHEMBL17876317 0.90 KDM4E (0.37) PIM1PIM3
SCHEMBL17877876 0.89 PRKDC (0.32) CYP11B1CYP11B2DRD2DRD4DRD3
SCHEMBL17875918 0.88 FLT3 (0.37) FLT3CYP11B1CYP11B2CYP19A1ROCK2
SCHEMBL17877849 0.88 KDM4E (0.39) CYP11B1CYP11B2DRD2DRD4DRD3
SCHEMBL17877736 0.88 KDM4E (0.39) CYP11B1CYP11B2DRD2DRD4DRD3
SCHEMBL17877737 0.88 KDM4E (0.39) CYP11B1CYP11B2DRD2DRD4DRD3
SCHEMBL17877911 0.88 KDM4E (0.39) CYP11B1CYP11B2DRD2DRD4DRD3
SCHEMBL17877878 0.88 MYC (0.37) FLT3ABCG2DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 FLT3 2778/4885CYP11B1 938/4885CYP11B2 1374/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 FLT3 2778/4885CYP11B1 938/4885CYP11B2 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.